{"id":20076,"date":"2025-08-04T11:13:13","date_gmt":"2025-08-04T09:13:13","guid":{"rendered":"https:\/\/www.invest-in-toulouse.fr\/centres-of-excellence\/sante\/"},"modified":"2026-01-21T10:50:09","modified_gmt":"2026-01-21T09:50:09","slug":"healthtech","status":"publish","type":"page","link":"https:\/\/www.invest-in-toulouse.fr\/en\/centers-of-excellence\/healthtech\/","title":{"rendered":"Healthtech"},"content":{"rendered":"\n
\n
\n
\n

The HealthTech sector, Toulouse’s economic driver, is supported by eight hospitals, nine clinics, 2,200 researchers and the Campus Sant\u00e9 du Futur (Health Campus of the Future), Oncopole.<\/p>\n\n\n\n

Key areas of excellence include biotherapies, bioproduction, digital health, artificial intelligence, gerosciences and the fight against cancer (prevention, diagnosis, therapies). This ecosystem attracts talent, businesses and investors, strengthening the local economy while stimulating innovation.<\/p>\n<\/div>\n\n\n\n

\n
\"Campus\n\t\t\t\n\t\t\t\t\n\t\t\t<\/svg>\n\t\t<\/button>
Campus “Sant\u00e9 du Futur” \u00a9 R\u00e9mi Deligeon<\/figcaption><\/figure>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
\n

Biotherapies\/Bioproduction<\/h2>\n\n\n\n

Toulouse M\u00e9tropole is a major hub for bioproduction and biotherapies in the Occitanie region, which has invested \u20ac36 million to support the sector since 2017. In 2024, Evotec inaugurated its J.POD\u00ae 2 plant (\u20ac150 million, 15,000 m\u00b2) on the Campus Sant\u00e9 du Futur to produce 2 tonnes of biological products per year, strengthening European health sovereignty. Toulouse Industrial Biotechnology for Health also plays a key role in bringing together research and industry to accelerate the production of biomedicines.<\/p>\n<\/div>\n\n\n\n

\n

Digital Health<\/h2>\n\n\n\n

Toulouse is at the forefront of digital health, with patient monitoring applications, connected medical devices and artificial intelligence-based solutions. ANITI’s AI for Health programme, launched in 2023, brings together local players to develop innovative technologies. Certified French Tech Health Tech, Toulouse supports a dynamic ecosystem, with the Toulouse Digital Health third place funded to the tune of \u20ac1.5 million by the French government. ANITI and TSN are strengthening innovation for preventive and personalised medicine.<\/p>\n<\/div>\n\n\n\n

\n

Pharmaceuticals<\/h2>\n\n\n\n

Toulouse is a leader in pharmaceutical research and development, notably with Pierre Fabre, a major player in cancer research and innovative therapeutic solutions. Evotec, a key CRO, supports pharmaceutical innovation by co-developing cutting-edge treatments. Finally, the entire Toulouse ecosystem supports industrial relocation, notably with Ipsoph\u00e8ne, which produces 100% French paracetamol active ingredients.<\/p>\n<\/div>\n\n\n\n

\"Diagnostics<\/span>
\n

Diagnostics<\/p>\n\n\n\n

Toulouse also excels in the field of medical diagnostics, with major investments such as Siemens Healthineers, for the production of radiopharmaceuticals for positron emission tomography (PET) diagnostics. In 2025, IUCT-Oncopole took another step forward in medical innovation by installing a second 100% digital PET scanner and setting up an interventional radiology room within its operating theatre. These innovations are all aimed at improving the diagnosis and care of cancer patients.<\/p>\n<\/div><\/div>\n\n\n\n

\n
\n
\n
\n
\"IUCT\n\t\t\t\n\t\t\t\t\n\t\t\t<\/svg>\n\t\t<\/button>
IUCT Oncopole \u00a9 R\u00e9mi Deligeon<\/figcaption><\/figure>\n<\/div>\n\n\n\n
\n

Innovation<\/p>\n\n\n\n

Campus “Sant\u00e9 du Futur”<\/h2>\n\n\n\n

On the banks of the Garonne River, the Campus “Sant\u00e9 du Futur” (The Future of Health) embodies Toulouse’s excellence in medical and biotechnological innovation. This exceptional site brings together researchers, companies and cutting-edge infrastructure in a sustainable and connected environment.<\/p>\n\n\n\n

\n
Campus Sant\u00e9 du Futur<\/a><\/div>\n<\/div>\n\n\n\n
<\/div>\n<\/div>\n<\/div>\n<\/section>\n\n\n\n
\n
\n

IUCT-Oncopole<\/h3>\n\n\n\n

The Toulouse University Cancer Institute \u2013 Oncopole is a cancer centre combining care, research and teaching. It brings together the Claudius Regaud Institute, Toulouse University Hospital and Paul Sabatier University. Its mission is to offer patients rapid access to innovative treatments.<\/p>\n\n\n\n

Campus Sant\u00e9 du Futur<\/p>\n<\/div>\n\n\n\n

\n

CRCT<\/h3>\n\n\n\n

The Toulouse Cancer Research Centre is a research laboratory dedicated to studying the mechanisms of cancer. It brings together researchers, clinicians and industrialists to develop new therapies and aims to accelerate the transfer of scientific discoveries to patients.<\/p>\n\n\n\n

Campus Sant\u00e9 du Futur<\/p>\n<\/div>\n\n\n\n

\n

Laboratoires Pierre Fabre<\/h3>\n\n\n\n

The Pierre Fabre Group is a major player in the fields of pharmaceuticals, oncology and dermo-cosmetics. The Campus site employs around 1,000 people and is dedicated to R&D in oncology. Another Pierre Fabre centre is located in the heart of Toulouse, at the H\u00f4tel-Dieu, and is dedicated to skin research and the evaluation of dermo-cosmetic products.<\/p>\n\n\n\n

Campus Sant\u00e9 du Futur<\/p>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

\n
\n
\n

#chooseToulouse<\/p>\n\n\n\n

Alia Sant\u00e9<\/h2>\n\n\n\n

Toulouse Team – Invest accompanied and supported Alia Sant\u00e9, a pioneering company specialising in artificial intelligence in the healthcare sector, in the process of establishing itself in Toulouse.<\/p>\n<\/div>\n\n\n\n

\n
\n